Hartmut Ehrlich: CEO of Abivax

Portrait of Hartmut Ehrlich

Hartmut Ehrlich,  CEO of Abivax, shares his thoughts with BioBoss host John Simboli about leadership in biopharma and how Abivax is working to develop treatments modulating the body’s natural immune system to treat patients with chronic inflammatory diseases, viral infections and cancer.

Alexion Pharmaceuticals

Rare Heroes

Steinway Annual Report cover detail
Steinway Musical Instruments

Extending Our Reach

Agents A Palette of Therapies video screenshot
Agenus

A Palette of Therapies